The future: Systemic pathologies

Numerous scientific publications support the efficacy and safety of mesenchymal stem cells in the treatment of systemic diseases such as chronic renal failure or inflammatory bowel disease (IBD).

Horstem - ecografía
In recent years, the intravenous use of stem cells to treat numerous systemic and autoimmune pathologies has been investigated due to their immunomodulatory potential. However, there are still no stem cell-based medicine approved for this use.
  • Insuficiencia renal
  • IBD
  • Dermatitis atópica
  • Problemas oftalmológicos
  • Heridas